We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORA:ASXOrora Limited Analysis

Data as of 2026-06-12 - not real-time

A$1.39

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Orora Limited is trading at AUD 1.39, comfortably above its 20‑day SMA (1.30) but still below the 50‑day (1.41) and 200‑day (1.93) averages, signaling short‑term momentum within a longer‑term bearish backdrop. The MACD histogram has turned positive and the MACD line sits above its signal line, offering a bullish technical signal, while the RSI sits at 56, indicating neutral momentum without overbought pressure. Fundamentals show a respectable 9.7% revenue growth, low valuation multiples (P/E 13.9, forward P/E 11.2, P/B 0.62) and a DCF‑derived fair value of AUD 2.77, implying roughly 32% upside potential. However, the dividend yield is high at 7.4% but the payout ratio exceeds 100%, raising concerns about dividend sustainability. Volatility is elevated at 34% over the past 30 days and the stock has experienced a historic max drawdown of nearly 47%, reflecting a risk‑on environment for price swings. Overall, the combination of undervaluation and modest growth supports a buy case, but the elevated volatility, sector cyclicality, and dividend risk temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD crossover and price above 20‑day SMA
  • Support level at AUD 1.24 providing downside cushion
  • High dividend yield but unsustainable payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicating ~32% upside
  • Revenue growth of ~10% and low price multiples
  • Stable trading volume and low beta reducing market‑wide risk

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued balance sheet with P/B below 1
  • Potential for dividend policy adjustment improving sustainability
  • Exposure to diversified markets (AU, NZ, US) mitigating geographic concentration

Key Metrics & Analysis

Financial Health

Revenue Growth9.70%
Profit Margin5.68%
P/E Ratio13.9
ROE4.35%
ROA3.62%
Debt/Equity28.95
P/B Ratio0.6
Op. Cash FlowA$412.5M
Free Cash FlowA$199.3M

Technical Analysis

TrendBearish
RSI56.5
SupportA$1.24
ResistanceA$1.40
MA 20A$1.30
MA 50A$1.41
MA 200A$1.93
MACDBullish
VolumeStable
Fear & Greed Index86.71

Valuation

Fair ValueA$2.77
Target PriceA$1.84
Upside/Downside32.50%
GradeUndervalued
TypeBlend
Dividend Yield7.41%

Risk Assessment

Beta-0.02
Volatility33.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.